Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-06-07
1996-12-17
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514730, 564283, 568722, A61K 3114, A61K 31055, C07C21163, C07C 3915
Patent
active
055854044
ABSTRACT:
Use of a compound selected from the group consisting of 3,5-diiodo-4-(2-N,N-diethylaminoethoxy)phenyl-(2-butylbenzofur-3-yl)methan ol hydrochloride (001), 2-methyl-3-(3,5-diiodo-4-(2-N,N-diethylaminoethoxy)-benzoyl)benzofuran hydrochloride (003), 2-n-butyl-3-(3,5-diiodo-4-carboxymethoxybenzoyl)benzofuran (005), 2-methyl-3-(3,5-diiodo-4-hydroxy-benzoyl)benzofuran (011), 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (015), 4'-hydroxy-3'-iodo-3,5-diiodo-4-(2-N,N-diethylaminoethoxy)benzophenon hydrochloride (024), 2-butyl-3-(3-iodo-4-hydroxybenzoyl)benzofuran (029), 4'4'-dihydroxy-3'3,5-triiododiphenylmethan (032), which compound is a 3,5,3'-triiodothyronine (T-3) receptor ligand, for the preparation of a medicament for the therapeutic or prophylactic treatment of a disorder which depends on the expression of T-3 regulated genes, and pharmaceutical preparations comprising said compounds, are disclosed. Further, a method of prophylactically or therapeutically treating a patient having a disorder which depends on the expression of 3,5,3"-triiodo-thyronine (T-3) regulated genes is also disclosed. The invention additionally comprises product protection for all the above listed compounds, except the compound (011).
REFERENCES:
Balani R A, Sethna S (1971). J. Indian Chem Soc. 48(5) 417-22. (abstract).
Balabaskaran S, Smith J N (1970) Biochem J. 117(5) 989-96. (abstract).
Bajorath Jurgen
Norinder Ulf
Stearns Jay F.
Huang Evelyn
Ivy C. Warren
LandOfFree
3,5,3'-triiodothyronine receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,5,3'-triiodothyronine receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,5,3'-triiodothyronine receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991638